According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -8,27ย โฌ. In 2024 the company made an earnings per share (EPS) of -22,09ย โฌ an increase over its 2023 EPS that were of -83,90ย โฌ.